🟠 Moderate Evidence
The dietary supplement industry markets ubiquinol as the superior form of coenzyme Q10 (CoQ10), claiming it is already in the form your body needs and therefore absorbs more efficiently than ubiquinone. However, research published in Nutrition (2019) and analysed in Antioxidants (2020) reveals that the actual determinant of CoQ10 absorption has little to do with which form appears on the label. Instead, manufacturing formulation process matters far more than whether the supplement contains ubiquinol or ubiquinone.
Key takeaways
- Your body converts between ubiquinone and ubiquinol constantly; approximately 95–98% of CoQ10 in your bloodstream circulates as ubiquinol regardless of which form you ingest
- According to Lopez-Lluch et al. (Nutrition, 2019), bioavailability varied roughly 10-fold across seven different CoQ10 products, but the variation correlated with formulation technology, not chemical form
- Crystal-dispersed ubiquinone achieved approximately twice the absorption of ubiquinol in soft gel capsules, according to analysis by Mantle and Dybring (Antioxidants, 2020)
- Marketing claims that ubiquinol “skips a step” misrepresent fundamental cellular biochemistry and override evidence-based product selection criteria
Your body converts CoQ10 forms automatically
CoQ10 is a redox-active molecule—it functions by cycling between two chemical states in your mitochondrial respiratory chain. Ubiquinone is the oxidized form; ubiquinol is the reduced form. When you swallow ubiquinone, cells lining your small intestine (enterocytes) reduce it to ubiquinol during absorption. When you swallow ubiquinol, some of it oxidizes back to ubiquinone before reaching the intestine because ubiquinol is chemically unstable in the presence of oxygen.
This conversion is not a rate-limiting step for your body. The molecular machinery performing these conversions has been operating continuously throughout your life. Regardless of whether you consume ubiquinone or ubiquinol, approximately 95–98% of the CoQ10 circulating in your blood exists in the ubiquinol form, according to biochemical analysis cited in the source materials. The body does not struggle with this conversion; it is a background physiological process as routine as breathing.
CoQ10 Form Does Not Predict Blood Levels
Percentage of ubiquinol in circulation regardless of supplement form ingested
Source: Lopez-Lluch et al., Nutrition 2019; Mantle & Dybring, Antioxidants 2020 | Georgian Medical Journal News
Formulation technology trumps chemical form
The decisive 2019 study appears in Nutrition. Researchers led by Lopez-Lluch tested seven different commercially available CoQ10 formulations in a randomized crossover trial with 14 healthy adults. They measured area under the curve (AUC)—a standard pharmacokinetic measure of how much drug reaches your bloodstream and for how long. The results were striking: AUC values ranged approximately 10-fold across the seven products.
However, when Mantle and Dybring analyzed this data in Antioxidants (2020), they revealed the true driver of absorption. Ubiquinol in a soft gel capsule achieved approximately twice the AUC of untreated ubiquinone. But here is the critical finding: ubiquinone that had undergone crystal dispersion—a manufacturing process that breaks apart the CoQ10 crystal lattice so it dissolves in gastrointestinal fluid—achieved roughly double the AUC of ubiquinol. The formulation technology mattered more than the chemical form.
Ubiquinone that had been crystal-dispersed achieved approximately twice the bioavailability of ubiquinol in soft gel capsules, contradicting marketing claims that ubiquinol is inherently superior.
— Mantle and Dybring, Antioxidants (2020)
What marketing claims omit about absorption
The marketing narrative rests on a logical-sounding but misleading premise: that your body “has to convert” ubiquinone to ubiquinol, and therefore taking ubiquinol “skips a step.” This framing ignores two biochemical realities. First, your cells actively use both forms in redox cycling; conversion is not a barrier but a normal functional process. Second, ubiquinol’s chemical instability—it oxidizes in the presence of oxygen—means some ubiquinol converts to ubiquinone before absorption even occurs, negating any theoretical advantage.
The Lopez-Lluch crossover study and its reanalysis by Mantle and Dybring establish that supplement bioavailability depends on how manufacturers formulate the product, not on whether the label reads “ubiquinone” or “ubiquinol.” A poorly formulated ubiquinol product will be absorbed less efficiently than a well-formulated ubiquinone product. Crystal dispersion, emulsification, lipid-based delivery systems, and particle size reduction—manufacturing innovations that cost money—determine absorption far more than the choice between two forms your body treats as functionally interchangeable.
Clinical implications and patient guidance
CoQ10 supplementation has documented benefits in specific populations. Research published in JACC Heart Failure (2014) found that CoQ10 supplementation reduced mortality and hospitalizations in heart failure patients. However, these clinical benefits do not depend on choosing ubiquinol over ubiquinone. When selecting a CoQ10 supplement, consumers and clinicians should prioritize product formulation—look for preparations with enhanced bioavailability technology—rather than being persuaded by marketing claims that one chemical form is universally superior to the other. The price premium charged for ubiquinol is not justified by absorption data.
What this means
Frequently asked questions
If my body converts ubiquinone to ubiquinol anyway, why do companies market ubiquinol?
Because ubiquinol commands a price premium. The conversion process is trivial for your cells but profitable for supplement manufacturers. Marketing emphasizes the logical-sounding idea of “skipping a step” while downplaying the biochemical reality that conversion is not a rate-limiting process and that ubiquinol’s own instability undermines theoretical advantages. Better formulation, not chemical form, determines what your body actually absorbs.
Does the evidence mean CoQ10 supplementation doesn’t work?
No. Studies including the 2014 JACC Heart Failure trial demonstrate clinical benefits for CoQ10 in specific populations, particularly heart failure patients. The evidence question is not whether CoQ10 works, but which formulation absorbs best. The answer: well-formulated ubiquinone often outperforms ubiquinol, contradicting supplement marketing.
What should I look for when buying CoQ10?
Prioritize formulations that enhance bioavailability through manufacturing processes such as crystal dispersion, lipid emulsification, or nano-particle technology. Ask the manufacturer or check the label for bioavailability data. Ignore claims that ubiquinol is inherently superior. Compare cost per dose and choose based on formulation quality, not chemical form marketing.
The CoQ10 market illustrates a broader pattern in supplement marketing: when a product’s inherent chemistry does not support a superiority claim, manufacturers emphasize formulation details that consumers cannot easily evaluate, then attach a premium price. The Lopez-Lluch and Mantle-Dybring evidence demonstrates that rigorous bioavailability testing, not marketing narratives about chemical forms, should guide both purchasing decisions and clinical recommendations. For CoQ10 users seeking cardiovascular or mitochondrial benefits, the data suggests that a well-formulated, affordable ubiquinone product will outperform a poorly formulated ubiquinol product every time.
Source: CoQ10 bioavailability analysis (Lopez-Lluch et al., 2019; Mantle & Dybring, 2020)
Was this article helpful?
Disclaimer. This article is health journalism intended for general information and education. It is not medical advice and is not a substitute for professional diagnosis or treatment. Always consult a qualified healthcare provider about your individual circumstances. Full disclaimer →
Related Coverage
Editorial standards. This article was produced under the GMJ News editorial process, with oversight by the GMJ Editorial Board. Our editorial process. Spotted an error? Contact the editorial team.
